{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:50:55Z","timestamp":1769082655245,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.amjcard.2019.11.030","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T04:42:42Z","timestamp":1575866562000},"page":"751-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-3968","authenticated-orcid":false,"given":"Giuseppe","family":"Patti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Cerchiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Bressi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia Delli","family":"Veneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germano","family":"Di Sciascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Avvisati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.11.030_bib0001","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamacardio.2016.3311","article-title":"Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: a subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"1","author":"Ruff","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0003","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0005","article-title":"Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0006","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00592-015-0746-8","article-title":"Is diabetes a hypercoagulable state? A critical appraisal","volume":"52","author":"Pomero","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2016.10.069","article-title":"Insulin-requiring versus noninsulin-requiring diabetes and thromboembolic risk in patients with atrial fibrillation: PREFER in AF","volume":"69","author":"Patti","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0008","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0030-1270072","article-title":"Hemostatic disorders in type 1 diabetes mellitus","volume":"37","author":"Targher","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0049-3848(92)90068-L","article-title":"Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus","volume":"67","author":"Carmassi","year":"1992","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0011","doi-asserted-by":"crossref","first-page":"e55396","DOI":"10.1371\/journal.pone.0055396","article-title":"The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus","volume":"8","author":"Oggianu","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0012","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0038-1648506","article-title":"The structure and function of von Willebrand factor","volume":"67","author":"Ruggeri","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/hrt.73.6.527","article-title":"Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin therapy","volume":"73","author":"Lip","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0014","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0015","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/01.STR.0000088642.07691.15","article-title":"Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels","volume":"34","author":"Santamar\u00eda","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1538-7836.2009.03663.x","article-title":"The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome","volume":"8","author":"Brouns","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0017","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00001721-199203040-00015","article-title":"Prothrombin fragment F1\u202f+\u202f2 and thrombin antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation","volume":"3","author":"Asakura","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0018","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vph.2011.03.005","article-title":"Cellular and molecular mechanisms of vascular injury in diabetes\u2013part I: pathways of vascular disease in diabetes","volume":"54","author":"Madonna","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vph.2011.03.007","article-title":"Cellular and molecular mechanisms of vascular injury in diabetes\u2013part II: cellular mechanisms and therapeutic targets","volume":"54","author":"Madonna","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2013.10.035","article-title":"Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants","volume":"113","author":"Pancholy","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2019.02.004","article-title":"Thrombotic and hemorrhagic burden in women: gender-related issues in the response to antithrombotic therapies","volume":"286","author":"Renda","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0022","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/europace\/euy215","article-title":"Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling","volume":"21","author":"Odening","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0023","first-page":"877","article-title":"The left atrial appendage: from embryology to prevention of thromboembolism","volume":"38","author":"Patti","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0024","first-page":"4907","article-title":"Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc score with and without atrial fibrillation","volume":"21","author":"Zhang","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0025","doi-asserted-by":"crossref","first-page":"e3145","DOI":"10.1002\/dmrr.3145","article-title":"The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation","volume":"35","author":"Patti","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2876","article-title":"Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials","volume":"33","author":"Patti","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0027","doi-asserted-by":"crossref","first-page":"41565","DOI":"10.1038\/srep41565","article-title":"Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?","volume":"7","author":"Garcia-Fernandez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41569-018-0080-2","article-title":"Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs","volume":"16","author":"Patti","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0029","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamacardio.2016.5224","article-title":"Atrial fibrillation, type 2 diabetes, and non\u2013vitamin K antagonist oral anticoagulants","volume":"2","author":"Plitt","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.030_bib0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919313554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919313554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:32:38Z","timestamp":1757572358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919313554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0002914919313554"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.11.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}